Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Philadelphia youth see rise in diagnosis; especially for African Americans, by 70%.
Read More »Increasing Incidence of Type 1 Diabetes In Children
Efficacy and Safety of Diacerein With Inadequately Controlled Type 2 Diabetes
Common osteoarthritis treatment may be beneficial in lowering HbA1c.
Read More »Intensive Control Again Shows Greater Benefits
Intensive control of blood pressure, glucose, and lipids benefits patients with type 2 diabetes, the long-awaited, large Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular Diseases (J-DOIT3).
Read More »Metformin For T1D Benefits – REMOVAL Study
The results of the REMOVAL study were presented at the 2017 European Association for the Study of Diabetes (EASD) in Lisbon
Read More »Ertugliflozin, An SGLT-2, Meets Goals in Two Phase 3 Trials
The investigational sodium/glucose cotransporter 2 (SGLT2) inhibitor ertugliflozin (Merck), being developed to improve glycemic control in adults with type 2 diabetes, met the primary outcomes in two yearlong phase 3 trials, VERTIS SU and VERTIS SITA2.
Read More »SGLT-2 Inhibitors Safer and More Effective Than DPP-4s For Heart
New study finds lower occurrence of heart failure in older people with type 2.
Read More »Benefits of CGM’s for Type 1 Patients
Real-time monitoring produces significant long-term improvement in HbA1c.
Read More »CGM Use For Type 1 Pregnant Women Randomized Trial- CONCEPTT Study
Study examined effectiveness of CGM on maternal glucose control and obstetric and neonatal health outcomes.
Read More »EASD: First Oral Drug for Type 1 Diabetes – Tandem3 Study – Sotagliflozin
Addition to insulin therapy helped reduce hemoglobin A1c levels, researchers reported.
Read More »PCPs Lack Knowledge of Prediabetes Risk
Recent published study showed that health care providers may lack the knowledge to diagnose and even treat prediabetes.
Read More »